Groupe Bruxelles Lambert SA (EBR:GBLB)
Belgium · Delayed Price · Currency is EUR | Market Cap | 8.83B -5.1% |
| Revenue (ttm) | 6.62B +9.3% |
| Net Income | -615.90M |
| EPS | -4.96 |
| Shares Out | 119.51M |
| PE Ratio | n/a |
| Forward PE | 26.19 |
| Dividend | 5.13 (7.11%) |
| Ex-Dividend Date | May 14, 2026 |
| Volume | 276,435 |
| Open | 74.00 |
| Previous Close | 73.85 |
| Day's Range | 73.55 - 74.08 |
| 52-Week Range | 71.30 - 85.65 |
| Beta | 0.68 |
| Analysts | Buy |
| Price Target | 88.73 (+20.15%) |
| Earnings Date | Nov 5, 2026 |
About Groupe Bruxelles Lambert
Groupe Bruxelles Lambert SA invests in a portfolio of industrial, consumer goods, and business service companies in Belgium, other European countries, North America, and internationally. It operates through six segments: Holding, Imerys, Canyon, Affidea, Sanoptis, and GBL Capital and Sienna Investment Managers. The company was incorporated in 1902 and is headquartered in Brussels, Belgium. [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 7 analysts, the average rating for GBLB stock is "Buy." The 12-month stock price target is €88.73, which is an increase of 20.15% from the latest price.
News
Groupe Bruxelles Lambert Earnings release: Q2 2026
Groupe Bruxelles Lambert released its Q2 2026 earnings on July 30, 2026, summarizing the period's financial results.
Groupe Bruxelles Lambert Slides: Q2 2026
Groupe Bruxelles Lambert has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 30, 2026.
Italy's Recordati says board finds CVC, GBL offer 'fair' as independent directors dissent
Recordati said on Wednesday that a majority of its board has deemed as "fair" an offer by private equity firm CVC Capital Partners and Belgian investment group Groupe Bruxelles Lambert to take the I...
CVC, Groupe Bruxelles Lambert Make $12.5 Billion Bid to Take Recordati Private
The consortium said the offer is aimed at delisting Recordati from Euronext Milan and supporting the drugmaker's expansion in rare diseases.
CVC, GBL launch 10.7 bln euro full takeover offer for Italy's Recordati
Private equity firm CVC Capital Partners and Belgian investment group GBL said on Friday they had launched a 10.7 billion euro ($12.43 billion) full voluntary cash bid on Italian pharmaceutical gro...
Groupe Bruxelles Lambert Earnings release: Q1 2026
Groupe Bruxelles Lambert released its Q1 2026 earnings on May 7, 2026, summarizing the period's financial results.
Groupe Bruxelles Lambert Slides: Q1 2026
Groupe Bruxelles Lambert has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 7, 2026.
Groupe Bruxelles Lambert Annual report: Q4 2025
Groupe Bruxelles Lambert has published its Q4 2025 annual report on March 12, 2026.
Groupe Bruxelles Lambert Earnings release: Q4 2025
Groupe Bruxelles Lambert released its Q4 2025 earnings on March 12, 2026, summarizing the period's financial results.
Groupe Bruxelles Lambert Slides: Q4 2025
Groupe Bruxelles Lambert has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 12, 2026.
Umicore - Transparency notification by Groupe Bruxelles Lambert S.A.
Transparency notification by Groupe Bruxelles Lambert S.A. In accordance with article 14, § 1 of the law of 2 May 2007 on the disclosure of major holdings, Umicore was recently notified by Groupe Brux...
Groupe Bruxelles Lambert Earnings release: Q3 2025
Groupe Bruxelles Lambert released its Q3 2025 earnings on November 6, 2025, summarizing the period's financial results.
Groupe Bruxelles Lambert Slides: Q3 2025
Groupe Bruxelles Lambert has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 6, 2025.